Allegiant Rx News
RxWIRE Newsletter – December 8, 2016
That didn't take long. Less than a week since Allergan CEO Brent Saunders implored pharma to take the initiative to defuse a public debate on drug pricing, Novo Nordisk has become the second player to make a cost pledge.
Read MoreRxWIRE Newsletter – December 1, 2016
The House plans to vote Wednesday on a $6.3 billion bill aimed at speeding federal approval of drugs and medical devices and boosting biomedical research.
Read MoreRxWIRE Newsletter – November 23, 2016
When presidential candidate Hillary Clinton blasted Martin Shkreli on Twitter for hiking the price of an old drug called Daraprim by 5,000% in September 2015, biotech stocks plummeted.
Read MoreRxWIRE Newsletter – November 17, 2016
When presidential candidate Hillary Clinton blasted Martin Shkreli on Twitter for hiking the price of an old drug called Daraprim by 5,000% in September 2015, biotech stocks plummeted.
Read More